The board withdrew six allegations against Dr. Nass, who criticized the government’s response to COVID-19 online.
Dr. Nass is still being accused of not keeping “complete, accurate and timely” records and lying to pharmacists about reasons for prescribing the drugs, as well as prescribing the drugs based on text messages with patients.
One hydroxychloroquine prescription Dr. Nass wrote allegedly included “no patient history, no physical examination, no medical decision-making, no patient informed consent, no coordination of care and no recommended follow-up,” according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.